Abstract
Cerebral microbleeds (CMBs) are a key biomarker of cerebral small vessel disease on magnetic resonance imaging, They have potential clinical relevance to future stroke risk. Therefore, the detection of CMBs has important clinical significance for various cerebrovascular disease phenotypes. This article briefly summarizes the detection method of CMBs, mainly investigating the clinical significance of CMBs in general population and in patients with ischemic stroke, cerebral hemorrhage, vascular cognitive impairment, cerebral amyloid angiopathy, and leukoaraiosis. Key words: Cerebral Hemorrhage; Cerebral Small Vessel Diseases; Magnetic Resonance Imaging; Stroke; Brain Ischemia; Cerebral Amyloid Angiopathy; Leukoaraiosis; Cognition Disorders
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
